Iphigenie Korakis, Martina Imbimbo, Emiliano Calvo, Sebastian Ochsenreither, Ignacio Ortego, Pascale Tomasini, Kaïssa Ouali, Alexander Desuki, Daniela Di Blasi, Eduard Gasal, Markus Joerger. "EXPAND-1, a phase I/II study with ANV600, a novel PD-1 targeted IL-2R-βγ agonist, in monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps2701